Inhibition of ribonucleotide reductase and growth of human colon carcinoma HT-29 cells and mouse leukemia L1210 cells by N-hydroxy-N′-aminoguanidine derivatives
- 1 October 1990
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 40 (8) , 1779-1783
- https://doi.org/10.1016/0006-2952(90)90356-p
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Design, synthesis, testing, and quantitative structure-activity relationship analysis of substituted salicylaldehyde Schiff bases of 1-amino-3-hydroxyguanidine tosylate as new antiviral agents against coronavirusJournal of Medicinal Chemistry, 1990
- Effects of N-Rydroxy-N'-aminoguanidine Isoquinoline in Combination With Other Inhibitors of Ribonucleotide Reductase on L1210 CellsJNCI Journal of the National Cancer Institute, 1988
- Inhibition of ribonucleotide reductase and L1210 cell growth by N-hydroxy-N′-aminoguanidine derivativesBiochemical Pharmacology, 1985
- Optimization of the Schiff bases of N-hydroxy-N'-aminoguanidine as anticancer and antiviral agentsJournal of Medicinal Chemistry, 1985
- Novel N-hydroxyguanidine derivatives as anticancer and antiviral agentsJournal of Medicinal Chemistry, 1984
- Role of ribonucleotide reductase in cell divisionPharmacology & Therapeutics, 1983
- Studies of N-hydroxy-N'-aminoguanidine derivatives by nitrogen-15 nuclear magnetic resonance spectroscopy and as ribonucleotide reductase inhibitorsJournal of Medicinal Chemistry, 1983
- Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agentsAdvances in Enzyme Regulation, 1981
- Role of ribonucleotide reductase in expression of the neoplastic programLife Sciences, 1981
- Synchronized mammalian cell cultures: III. Variation of ribonucleotide reductase activity during the replication cycle of Chinese hamster fibroblastsExperimental Cell Research, 1969